
Full-spectrum root extract, backed by the clinical trials behind the KSM-66 name.
| Origin | Madhya Pradesh, India |
| Indian subcontinent | Yes |
| Category | Ayurveda & Wellness Extracts |
| Retail price band | premium |
| Bulk / trade price band | Pricing under research |
| Sourcing status | Dossier researched from public sources — producer contact not yet established |
| Compliance status | Preliminary review complete (see below) — not yet legally verified |
Ashwagandha (Withania somnifera) root is traditionally processed via a water-based (non-alcohol) extraction into a full-spectrum root-only extract; KSM-66 specifically refers to a proprietary extraction process developed by Ixoreal Biomed that preserves the root's natural withanolide ratio without using alcohol or added withanolides, distinguishing it from cheaper leaf-based or chemically-spiked ashwagandha extracts.
Ashwagandha cultivation for extract-grade root is concentrated in Madhya Pradesh (notably the Neemuch-Mandsaur belt) and Rajasthan, India, which supply the bulk of India's commercial ashwagandha root; KSM-66 itself is manufactured and trademarked by Ixoreal Biomed Pvt Ltd, headquartered in India, with the extract backed by multiple published human clinical trials on stress, cortisol, and strength outcomes.
Ashwagandha is one of the best-selling adaptogens globally; branded KSM-66-labelled products command a premium over generic/unbranded ashwagandha extract due to clinical backing and ingredient-traceability marketing, with typical bulk ingredient pricing and finished-capsule retail sitting meaningfully above commodity ashwagandha powder. Target buyers are nutraceutical formulators, supplement brands, and wellness-focused retail.
CRITICAL: 'KSM-66' is a registered trademark of Ixoreal Biomed Inc. (USPTO Reg. No. 4551163), not a generic quality grade — using the term 'KSM-66 grade' on a product not actually licensed/sourced from Ixoreal is a trademark-infringement and mislabeling risk. The vendor must confirm a genuine supply/licensing relationship with Ixoreal Biomed (or an authorised distributor) before using the name; as an ingestible extract it also requires FSSAI (India)/DSHEA (US) dietary-supplement compliance, standardised withanolide-content labelling, and root-only (not whole-plant) sourcing disclosure since Withania somnifera leaf material carries different alkaloid profiles.
A working reference photograph is in place, captured from a freely-licensed Wikimedia Commons source (File:Ashwagandha Roots.jpg). Freely licensed per Wikimedia Commons hosting policy. Depicts Withania somnifera roots, the raw ingredient, not the branded KSM-66 finished extract itself. Treat this as a placeholder for marketing purposes: exact licence terms should be re-verified on the Commons file page, and original producer photography is recommended before final trade use.